Nationally Recognized Executives Join Triad Isotopes, Inc.’s Leadership Team

FOR IMMEDIATE RELEASE

CONTACT:

Erin Lasser

Senior Director, Marketing & Communications

407.455.6709 –  Elasser@triadisotopes.com

 

ORLANDO, FLORIDA (October 1, 2013) Triad Isotopes, Inc. (Triad) has announced the addition of two nationally-recognized executives to the company’s leadership team.  Kerry E. Gillespie, CPA, CGMA has joined the company as Chief Financial Officer (CFO) and Chief Operations Officer (COO).  Douglas Ash has joined the company as Chief Information Officer (CIO).  Both report to Dom Meffe, President & Chief Executive Officer (CEO).

“Adding two executives as experienced and seasoned as Kerry and Doug clearly demonstrates our commitment to building a great organization,” said Dom Meffe. “We continue to focus our investments on people, process and technology as we strengthen our company and prepare for future growth.”

As CFO/COO, Kerry Gillespie brings over twenty five years of healthcare management experience that will help position Triad for future growth beyond the company’s current position as the nation’s second largest nuclear pharmacy company.  Prior to joining Triad Isotopes, Gillespie served as Executive Vice President, Operations Finance with Health Management Associates, Inc. and as Chief Financial Officer for Radiation Therapy Services, Inc. and Ardent Health Services, LLC.  In addition to his extensive career as a healthcare executive, Gillespie also brings a unique perspective on the nuclear pharmacy industry, having served as a radiology technologist early in his career.

On his decision to join Triad Isotopes, Gillespie stated, “I am excited to join the Triad team as they continue to build industry leadership in the nuclear pharmacy space during this time of rapidly escalating change in the U.S. health care marketplace.  Triad’s reputation for integrity, coupled with its close relationships with its pharmacy leadership and customers, helped solidify my decision to join this dynamic organization.”  He and his wife Karen will relocate to the Orlando area from Naples, Florida.

As CIO, Douglas Ash holds more than thirty years of experience working for Fortune 50 companies within business, information technology, and executive leadership roles.  He served as Vice President and CIO, Global Training and Logistics, and Vice President, Health Services & Solutions, for Lockheed Martin in Orlando before moving to Triad Isotopes.  His career also includes thirteen years at IBM in a variety of information technology and management positions.

Ash currently serves as Chairman of the Information Technology Senior Manager Forum (ITSMF), where he helps prepare African-American IT professionals for senior-executive roles within Fortune 500 companies.  ITSMF offers executive career development, mentoring, and networking opportunities to advance high potential careers and build a pipeline of talent.

Ash commented “The nuclear pharmacy industry growth initiatives Triad is pursuing created an exciting opportunity for me to leverage my business leadership and technology experience to optimize the investments Triad is making.  My goal is to ensure the company continues to innovate in the future, and achieve its business objectives.”  Doug and his wife Maria reside in Orlando.

 

ABOUT TRIAD ISOTOPESWatch movie online The Transporter Refueled (2015)

Triad Isotopes, Inc. is a nationwide nuclear pharmacy company headquartered in Orlando, FL.  The company’s national network of over 60 locations serves 4 million patients each year, making Triad Isotopes the nation’s second-largest and fastest-growing radiopharmaceutical provider.  These specialized facilities provide the products used by hospitals and nuclear medicine operators to help diagnose and treat patients, primarily those with cardiac and cancer concerns.